ANTIBIOTIC SUSCEPTIBILITY OF BACTERIA ISOLATED FROM OPEN FRACTURE GRADE III PRESENTING TO DR. SOETOMO GENERAL HOSPITAL SURABAYA
Downloads
Background: Open fracture is a typical case in the orthopedics field. Infection in the open fracture can cause osteomyelitis. Antibiotic susceptibility test of patient specimen bacteria with open fracture aims to obtain the suitable antibiotic agents to treat infectious diseases caused by these bacteria.
Methods: This research is a descriptive study to assess Antibiotic susceptibility in the case of open fracture grade III in Dr. Soetomo General Hospital Surabaya. A total sampling was performed from microbiological culture results of patients diagnosed with open fracture grade III after debridement from October 2018 to September 2019. The identification of the microbes was based on Gram-positive and Gram-negative categories and the classification based on susceptibility to antibiotics classified into sensitive, intermediate, and resistant.
Results: Data from microbiological culture results of patients with a diagnosis of open fracture grade III after debridement in October 2018 to September 2019 in Dr. Soetomo General Hospital Surabaya showed 56 research subjects who met the criteria. Acinetobacter baumannii is the most common bacterial species found in the microbiological examination of patients with open fractures, 15.84%. Cefazoline and ceftriaxone showed low susceptibility. Meanwhile, levofloxacin showed a relatively good value of susceptibility in both Gram-positive and negative bacterial groups.
Conclusion: The antibiotic susceptibility pattern of bacteria from specimens in open fracture grade III patients in Dr. Soetomo General Hospital Surabaya varies between each species of bacteria isolate.
Ivan F. Rubel; Sean Lager. The Socio-economic Impact of Chronic Osteomyelitis: The Most Frequent Complication. Orthopaedic Trauma Association. 2004:67.
Tornetta P, Rocca GJ, Morshed S, Jones C, Heels-Ansdell D, Sprague S et al. Risk Factors Associated with Infection in Open Fractures of the Upper and Lower Extremities. J Am Acad Orthop Surg Glob Res Rev. 2020; 4(12): e20.00188.
Ryan SP, Pugliano V. Controversies in Initial Management of Open Fractures. Scand J of Surg. 2013;103:132-137.
Ahmend I, Zafar H, Lakhnana NK, Ishtiaq S. Hospital Antibiogram : A Necessity in Monitoring Sensitivity of Isolates and Rationale Use of Antibiotics. Microbiol Res J Int. 2016; 13(3): 1-8.
Sisay M, Worku T, Edessa D. Microbial epidemiology and antimicrobial resistance patterns of wound infection in Ethiopia: A meta-analysis of laboratory-based cross-sectional studies. BMC Pharmacol Toxicol. 2019;20(1):1-19.
Khan ZA, Siddiqui MF, Park S. Current and Emerging Methods of Antibiotic Susceptibility Testing. Diagnostics (Basel). 2019;9(2):49. Published 2019 May 3.
Blom A, Warwick D, Whitehouse MR. Apley and Solomon's System of Orthopaedics and Trauma; 2018.
Arti HR. Comparison of early versus delayed debridement in open fractures. Pakistan J Med Sci. 2012; 28(5): 856-859.
Court-brown CM, Bugler KE, Clement ND, Duckworth AD, Mcqueen MM. The epidemiology of open fractures in adults . A 15-year review. Injury. 2012; 43(6): 891-897.
Odatuwa-Omagbemi DO. Open fractures: Epidemiological pattern, initial management and challenges in a sub-urban teaching hospital in Nigeria. Pan Afr Med J. 2019;33:1-8.
Kale AR, Sonawane CS, Waghmare VU, Kalambe H. Open Fractures and Incidence of Infection in Tertiary Care Government Hospital. Int J of Sci Study. 2017; 5(403): 24-28.
Neidell MJ, Cohen B, Furuya Y, Hill J, Jeon CY, Glied S, et al. Costs of Healthcare- and Community- Associated Infections with Antimicrobial- Resistant Versus Antimicrobial-Susceptible Organisms. Clin Infect Dis. 2012; 55: 807-815.
Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, et al. Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2014; 30(12).
Hsueh P, Teng L, Chen C, Chen W. Pandrug-Resistant Acinetobacter baumannii Causing Nosocomial Infections in a University Hospital, Taiwan. Emerg Infect Dis. 2002; 8(8):827-832.
Jiang M, Liu L,Ma Y, Zhang Z, Li N, Zhang F, et al. Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii Isolated in Shanding, China. Front Microbiol. 2016;7.
Fishbain J, Peleg AY. Treatment of Acinetobacter Infections. Clin Infect Dis 2010; 51(1):79-84.
Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis. 2019; 8(12):751-762.
Jang J, Hur HG, Sadowsky MJ, Byappanahalli MN, Yan T, Ishii S. Environmental Escherichia coli: ecology and public health implications”a review. J Appl Microbiol. 2017; 123(3):570-581.
Abraham Y, Wamisho BL. Microbial susceptibility of bacteria isolated from open fracture wounds presenting to the err of black-lion hospital, Addis Ababa University, Ethiopia. African J Microbiol Res. 2009; 3(12):939-951.
Yang L, Jelsbak L, Lykke R, Damkií¦r S, Workman CT, Holm M. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA. 2011; 108(18):7481-7486.
Nseir S, Ader F, Lubret R, Marquette C. Pathophysiology of Airway Colonization in Critically ill COPD Patient. Current Drug Targets. 2011:514-520.
Fuentefria DB, Ferreira AE, Corçí£o G. Antibiotic-resistant Pseudomonas aeruginosa from hospital wastewater and super fi cial water : Are they genetically related ? J Environ Manage. 2011; 92(1): 250-255.
Giedrys-kalemba S. Phenotypic and genotypic characteristics of Pseudomonas aeruginosa strains isolated from hospitals in the north-west region of Poland. Pol J Microbiol. 2006; (May 2014).
Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context. 2018; 7:1-18.
Shi HJ, Kim JH, Kim NY, Lee JB, Eom JS. Environmental Culture of Bacteria at the Intensive Care Unit of a Tertiary Hospital in Korea: A Consideration for Improving Medical Environmental Safety and Healthcare-associated Infection. Korean J Heal assoc Infect Control Prev. 2020; 25(2): 105-114.
Otchwemah R, Grams V, Tjardes T, Shafizadeh S, Bäthis H, Maegele M, et al. Bacterial contamination of open fractures - Pathogens, antibiotic resistances and therapeutic regimes in four hospitals of the trauma network Cologne, Germany. Injury. 2015; 46: S104-S108.
Zhu H, Li X, Zheng X. A descriptive study of open fractures contaminated by seawater: Infection, pathogens, and antibiotic resistance. Biomed Res Int. 2017;2017.
Gustilo RB, Mendoza RM, Williams DN. Problems in the Management of Type III (Severe) Open Fractures. J Trauma Inj Infect Crit Care. 1984; 24(8):742-746.
P Patanwala AE, Radosevich JJ, Meshay I, Naderi M, Culver MA, Lee YG, et al. Cefazolin Monotherapy Versus Cefazolin Plus Aminoglycosides for Antimicrobial Prophylaxis of Type III Open Fractures. Am J Ther. 2019;8:1.
Depcinski SC, Nguyen KH, Ender PT. Cefazolin and an aminoglycoside compared with cefazolin alone for the antimicrobial prophylaxis of type III open orthopedic fractures. Int J Crit Illn Inj Sci. 2019;9(3):127-131.
Hand TL, Hand EO, Welborn A, Zelle BA. Gram-negative antibiotic coverage in Gustilo-Anderson type-III open fractures. JBJS. 2020 Aug 19;102(16):1468-74.
Aggarwal J, Lustrino J, Stephens J, Morgenstern D, Tang WY. Cost-Minimization Analysis of Dexmedetomidine Compared to Other Sedatives for Short-Term Sedation During Mechanical Ventilation in the United States. ClinicoEconomics and Outcomes Research: CEOR. 2020;12:389.
Copyright (c) 2021 JOINTS (Journal Orthopaedi and Traumatology Surabaya)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- The author acknowledges that the copyright of the article is transferred to the Journal of Orthopaedi and Traumatology Surabaya (JOINTS), whilst the author retains the moral right to the publication.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License (CC BY-NC-SA).
- All published manuscripts, whether in print or electronic form, are open access for educational, research, library purposes, and non-commercial uses. In addition to the aims mentioned above, the editorial board is not liable for any potential violations of copyright laws.
- The form to submit the manuscript's authenticity and copyright statement can be downloaded here.
Journal of Orthopaedi and Traumatology Surabaya (JOINTS) is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License.
Journal Orthopaedi and Traumatology Surabaya (JOINTS) (